| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Ind-Swift Laboratories Limited (NSE: INDSWFTLAB)
INDSWFTLAB Technical Analysis
5
| As on 26th Oct 2021 INDSWFTLAB Share Price closed @ 59.20 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 77.99 & Strong Sell for SHORT-TERM with Stoploss of 66.13 we also expect STOCK to react on Following IMPORTANT LEVELS. |
INDSWFTLAB Share Price
| Open | 58.00 | Change | Price | % |
| High | 60.50 | 1 Day | 1.30 | 2.25 |
| Low | 55.15 | 1 Week | -2.30 | -3.74 |
| Close | 59.20 | 1 Month | -4.65 | -7.28 |
| Volume | 111090 | 1 Year | 7.35 | 14.18 |
| 52 Week High 127.45 | 52 Week Low 46.85 | ||||
NSE INDIA Most Active Stocks
| IDEA | 10.40 | 0.00% |
| PNB | 45.85 | 2.12% |
| BANKBARODA | 99.90 | 3.52% |
| TATAPOWER | 225.30 | 5.48% |
| YESBANK | 13.45 | 0.75% |
| IDFCFIRSTB | 52.85 | 7.09% |
| JPPOWER | 4.75 | 1.06% |
| BHEL | 71.65 | 4.29% |
| CANBK | 193.35 | -4.26% |
| TATAMOTORS | 508.65 | 5.99% |
NSE INDIA Top Gainers Stocks
NSE INDIA Top Losers Stocks
| INDSWFTLAB Daily Charts |
INDSWFTLAB Intraday Charts |
Whats New @ Bazaartrend |
INDSWFTLAB Free Analysis |
|
|
INDSWFTLAB Important Levels Intraday
| RESISTANCE | 69.51 |
| RESISTANCE | 66.20 |
| RESISTANCE | 64.16 |
| RESISTANCE | 62.12 |
| SUPPORT | 56.28 |
| SUPPORT | 54.24 |
| SUPPORT | 52.20 |
| SUPPORT | 48.89 |
INDSWFTLAB Target for Month October
| 4th UP TARGET | 82.03 |
| 3rd UP TARGET | 76.34 |
| 2nd UP TARGET | 72.83 |
| 1st UP TARGET | 69.31 |
| 1st DOWN TARGET | 59.29 |
| 2nd DOWN TARGET | 55.77 |
| 3rd DOWN TARGET | 52.26 |
| 4th DOWN TARGET | 46.57 |
INDSWFTLAB Weekly Target
| 4th UP TARGET | 69.46 |
| 3rd UP TARGET | 66.15 |
| 2nd UP TARGET | 64.11 |
| 1st UP TARGET | 62.07 |
| 1st DOWN TARGET | 56.23 |
| 2nd DOWN TARGET | 54.19 |
| 3rd DOWN TARGET | 52.15 |
| 4th DOWN TARGET | 48.84 |
INDSWFTLAB Target for Year 2021
| 4th UP TARGET | 173.82 |
| 3rd UP TARGET | 138.04 |
| 2nd UP TARGET | 115.92 |
| 1st UP TARGET | 93.81 |
| 1st DOWN TARGET | 30.69 |
| 2nd DOWN TARGET | 8.58 |
| 3rd DOWN TARGET | -13.54 |
| 4th DOWN TARGET | -49.32 |
Ind-Swift Laboratories Limited ( NSE INDIA Symbol : INDSWFTLAB )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
INDSWFTLAB Synopsis Technicals View
| 50 Day EMA |
Close is Above EMA 50 (Short Term) |
Bullish | |
| 100 Day EMA | Close is Above EMA 100 (Mid Term) | Bullish | |
| 200 Day EMA | Close is Above EMA 200 (Long Term) | Bullish | |
| MACD (12 26 9) | MACD Line is Grater Then SIGNAL Line | Bullish | |
| RSI (14) | RSI is 50.49 | Sideways | |
| MFI (14) | MFI is 46.81 | Sideways | |
| CCI (20) | CCI is 13.92 | Sideways | |
| WILLIAM %R (14) | William %R is -28.07 | Sideways | |
| ADX (14) | ADX is Above 20 & +DI is Below -DI | Down Trend | |
| PSAR | Stoploss For Long Buy | 15.06 | |
| 10 Day Avg Volume | Traded 60.16 % More then 10 Day Average Volume | ||
INDSWFTLAB Other Details
| Segment | EQ | |
| Market Capital | 3489071104.00 | |
| Sector | Healthcare | |
| Industry | Drug Manufacturers-Specialty & Generic | |
| Offical website | > | |
INDSWFTLAB Address
 |
||
INDSWFTLAB Latest News
INDSWFTLAB Business Profile
Ind-Swift Laboratories Limited develops, manufactures, and sells active pharmaceutical ingredients (APIs) in India. The company offers APIs in various therapeutic areas, including macrolide antibiotic, cardiovascular, antihistaminic, antidiabetic, antipsychotic, bone resorption inhibitor, antimigraine, Parkinson disease, hyperparathyrodism, analgesic, aromatase inhibitor, nootropic, antidiarrhoeal/antiprotozoal, anticholinergic, sedative, hypnotic, alcohol abstinence, and antineoplastic, as well as various products for ADHD symptoms. It provides reference standards and impurities for acamprosate calcium, anastrozole, aripiprazole, aripiprazole, atorvastatin calcium, bexarotene, cinacalcet hydrochloride, clopidogrel bisulphate, Clarithromycin, ezetimibe, fexofenadine hydrochloride, imatinib mesylate, ivabradine hydrochloride, ivabradine oxalate, letrozole, mecloxamine citrate, naratriptan hydrochloride, nitazoxanide, quetiapine, ropinirole hydrochloride, rosuvastatin calcium, saxagliptin monohydrate, silodosin, and temozolomide. The company also offers early and late phase drug development, process research and development, contract and API manufacturing, and custom chemicals and synthesis; and analytical development, regulatory support, chemistry, impurity profiling, isolation, discovery, identification and characterization, and project management services. It also exports its products. Ind-Swift Laboratories Limited was founded in 1995 and is based in Manimajra, India. Address: Shivalik Enclave, Manimajra, India, 160101
© 2005-2021 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service